This is a good direction.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
数学の次はこっちですか。
どんどん、fussy になり、困難度が高まる領域に挑戦していますね。
これは、当然、光だけでなくヤベー奴らが影も生み出すと思いますが、どうなるのだろう、、、この世界は、、、！
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
OpenAI 收了 Orchestra Bio，一个帮药企协调药物研发流程的平台，并进 Rosalind（它的生命科学模型和工具线）。
有意思的是，买的不是实验室也不是模型，是"项目管理"。新药慢，很多时候卡的不是科学，是排期和协调。AI 先去药厂当 PM，挺务实。
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
OpenAIが創薬業務支援のOrchestra Bioを買収し、生命科学向けのRosalindと統合へ。研究だけでなく、複雑な開発工程の調整にもAIを使う流れが強まります。
・研究結果と次の試験／判断をつなぐ
・研究や製造工程の進捗をAIエージェントが追跡
・遅延要因と影響範囲を整理
・最終判断は科学者や責任者が行う
活用案：研究プロジェクトの情報整理、進捗可視化、会議準備の導入支援。医療判断や研究判断は専門家が担い、機密情報・規制・利用条件の確認が前提です。
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
Looking forward to seeing the results
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
The inevitable trend of the big labs, the outputs of their best models worth more than the dollars from renting them.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
We can discover drugs at the speed of silicon.
We still make them at the speed of cells.
AI is about to flood the pipeline with new drugs. The next bottleneck isn't finding them. It's making them. 🧵
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
AI can find a new drug candidate in days. So why does it take years to reach you?
@biogerontology says people “overestimate the capabilities of AI and underestimate the complexity of biology.” For some conditions, trials still take a decade.
That gap is now on @OpenAI's radar. This week, it bought Orchestra Bio, which uses AI agents to keep drug programmes on track.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
Great! Let's go cure some Deseases
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
Congratulations @OpenAI and @ashokaraj_! 🧠🔬
Now let's put GPT-Rosalind and Orchestra Bio to work on multiple sclerosis.
Investigate cholesterol trafficking, oligodendrocyte maturation, and remyelination.
Let's turn AI-generated hypotheses into validated treatments.
🤖 Made with AI
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
Orchestra Bio is a small deal with a big signal.
OpenAI isn't just selling a chatbot to biotech. It's buying the boring layer: tracking trials, timelines, delays. Whoever owns the workflow owns the customer.
Models get commoditized. Workflow doesn't.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
Platform labs are going vertical. Orchestra Bio isn't a smarter chatbot, it's agents that know a regulated drug development workflow.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
Every major AI lab wants exposure to drug discovery. OpenAI now joins Anthropic, Google and co in acquisitions that give them access to pharma upside.
If Bittensor is to become the decentralized analogue it needs it too.
NOVA is that piece of the puzzle.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
AI + Biology = Accelerated innovation in health sciences.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
The interesting part of the deal is the coordination layer. Drug development takes 10 to 15 years, and OpenAI's own example is a failed batch forcing a trial reschedule. Agents map the damage; people decide. Automation gets the schedule. Humans keep the authority.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
⚡M&A Brief⚡
OpenAI has acquired Orchestra Bio, a platform where biopharma teams and AI agents work together to advance drug programs. When an issue comes up in one part of a program, its agents help teams see which activities and timelines are affected.
Orchestra's team and technology will join Rosalind, OpenAI's life sciences offering. Terms were not disclosed.
Source: OpenAI, Axios
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
OpenAI and Anthropic seem interested in monetizing through pharma. I like this more than their API business.
Not sure how this plays out, but there are a ton of really interesting implications if people live healthier and longer.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
ثغرات PHP الحرجة الجديدة (CVE-2026-109618 & 109619): حين يقرأ الذكاء الاصطناعي كوداً عمره عقود في دقائق
استيقظت الأوساط التقنية اليوم على إعلان رسمي عن ثغرتين حرجتين في لغة PHP برمز CVE-2026-109618 وCVE-2026-109619، بمستوى خطورة بلغت 9.2/10، وتتيحان تنفيذ أوامر برمجية عن بعد (RCE) دون الحاجة لأي تسجيل دخول.
1. المشهد التقني للاكتشاف:
دور الذكاء الاصطناعي: ما جعل هذه الموجة استثنائية هو أن الثغرتين اكتُشفتا بمساعدة نماذج ذكاء اصطناعي متقدمة (مثل استخدام نموذج GPT-5.6 Sol ضمن مبادرة «Patch the Planet» من باحثي Calif، واكتشاف مستقل من شركة Wiz). الآلة أصبحت تفكك شيفرات C العتيقة التي بنيت عليها PHP وتكتشف ثغرات بنيوية عجز عنها البشر لعقود.
سباق التسلح: الإفصاح المنسق منح صناع السياسات فرصة لإصدار التحديثات، لكن وكما هو متوقع في عصر الذكاء الاصطناعي، فإن المهاجمين يملكون نفس الأدوات؛ حيث ظهرت أكواد الاستغلال العلنية (PoC) وبدأت الهجمات التلقائية بعد ساعات قليلة من الإعلان.
2. خطة المعالجة الفورية المعتمدة:
الاعتماد على جدران الحماية (WAF) كحماية مسبقة (مثل تدابير Cloudflare المبكرة) هو خط دفاع أول، لكنه لا يلغي الجذور. على مستوى البنى التحتية الحية، تم التعامل مع الحدث وفق القاعدة الهندسية الصارمة:
الترقية الفورية للحزم المصححة: الانتقال المباشر للإصدارات الأمنية المستقرة (مثل PHP 8.3.36, 8.4.27, 8.5.12, 8.2.35) أو اعتماد حزم التوزيعات المحدثة (مثل Ubuntu USN-8948-1).
إعادة تشغيل عمال التشغيل (PHP-FPM Restart): لضمان تطهير الذاكرة العشوائية وإيقاف أي عمليات معلقة.
التدقيق الصامت: فحص مسارات العمل عبر بيئات النشر المعزولة لضمان عدم تسلل أي استغلال أولي.
3. الدرس الأكبر للمنظومات الرقمية:
في عصر تنشط فيه النماذج الذكية لاكتشاف الثغرات، الفائز ليس من يمتلك كوداً آمناً بالمطلق (فلا وجود لأمان تام)، بل من يمتلك منظومة مراقبة وأتمتة ذاتية ترصد، تختبر، وتغلق الثغرات قبل أن تتحول إلى كارثة تشغيلية.
الاستجابة الفورية وتأمين خوادمنا اليوم يعكسان بوضوح أن الفارق الحقيقي يكمن في سرعة الاستجابة الهندسية واستباق حركة المهاجمين.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
OpenAI의 Rosalind는 생명과학 연구자용 AI 도구이고,
이번에 인수한 Orchestra Bio는 복잡한 개발 프로그램의 운영, 일정,워크플로 구축·공유를 하는 AI 에이전트다.
과학적 발견부터 필요한 후속 연구,의사결정을 다음 단계의 에이전트가 연결해주는 시스템을 OpenAI가 만들어낼 수 있을지도 모르겠다.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
openai.com/index/openai-to-a…